or Try an Advanced Search...

    Technical Analysis for NYR - Nyrada Inc.

    Grade Last Price % Change Price Change
    B 0.096 -2.04% -0.002
    NYR closed down 2.04 percent on Wednesday, April 24, 2024, on 5 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Up Down
    Historical NYR trend table...
    Date Alert Name Type % Chg
    Narrow Range Bar Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    1,2,3 Pullback Bullish Bullish Swing Setup -2.04%
    Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -2.04%
    Narrow Range Bar Range Contraction -2.04%
    Inside Day Range Contraction -2.04%
    Wide Bands Range Expansion -2.04%
    Oversold Stochastic Weakness -2.04%
    1,2,3 Pullback Bullish Bullish Swing Setup -2.04%
    Older End-of-Day Signals for NYR ...

       Recent Intraday Alerts

    Alert Time
    Down 2% 2 days ago
    Fell Below Previous Day's Low 2 days ago
    Down 1% 2 days ago
    Up 2% 3 days ago
    Up 1% 3 days ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    NYR Chart by TradingView
    Basic chart:

    Profile

    Nyrada Inc (NYR) is a preclinical stage, drug development company. The Company specialises in the development of novel small molecule drugs pertaining to the underlying pathological processes involved in cardiovascular, neurodegenerative and chronic inflammatory diseases. It focuses on areas of substantial unmet clinical need and has identified drug candidates with therapeutic and commercial potential, where few if any, effective or well-tolerated therapies exist. It currently has three wholly-owned drug programs:
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Disease Diseases Drugs Drug Development

    Is NYR a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 5 bullish, 0 bearish and 0 neutral indicators. You may wish to incorporate that into your trading strategies.

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 0.17
    52 Week Low 0.018
    Average Volume 6,106,340
    200-Day Moving Average 0.056
    50-Day Moving Average 0.082
    20-Day Moving Average 0.104
    10-Day Moving Average 0.102
    Average True Range 0.011
    RSI (14) 49.49
    ADX 42.54
    +DI 35.724
    -DI 19.655
    Chandelier Exit (Long, 3 ATRs) 0.118
    Chandelier Exit (Short, 3 ATRs) 0.117
    Upper Bollinger Bands 0.127
    Lower Bollinger Band 0.080
    Percent B (%b) 0.34
    BandWidth 45.516
    MACD Line 0.003
    MACD Signal Line 0.007
    MACD Histogram -0.0033
    Fundamentals Value
    Market Cap 10.51 Million
    Num Shares 109 Million
    EPS -99999.99
    Price-to-Earnings (P/E) Ratio 0.00
    Price-to-Sales 0.00
    Price-to-Book 4.35
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.099
    Resistance 3 (R3) 0.099 0.099 0.099
    Resistance 2 (R2) 0.099 0.098 0.099 0.098
    Resistance 1 (R1) 0.097 0.097 0.097 0.097 0.098
    Pivot Point 0.097 0.097 0.097 0.097 0.097
    Support 1 (S1) 0.095 0.096 0.095 0.095 0.094
    Support 2 (S2) 0.095 0.095 0.095 0.094
    Support 3 (S3) 0.093 0.095 0.094
    Support 4 (S4) 0.093